SS&C Technologies Holdings Inc [SSNC] Filings

10-Q 1 ssnc-20240331.htm 10-Q 10-Q

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 10-Q


☒	QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended March 31, 2024


☐	TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from to

Commission File Number 001-34675

SS&C TECHNOLOGIES HOLDINGS, INC.

(Exact name of Registrant as specified in its charter)

    Delaware

    71-0987913

    (State or other jurisdiction of
incorporation or organization)

    (I.R.S. Employer
Identification No.)

80 Lamberton Road

Windsor, CT 06095

(Address of principal executive offices, including zip code)

860-298-4500

(Registrant’s telephone number, including area code)

Indicate by check mark whether the registrant: (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). Yes ☒ No ☐

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company” and “emerging growth company” in Rule 12b-2 of the Exchange Act. (Check one):


Large accelerated filer	☒	Accelerated filer	☐
Non-accelerated filer	☐	Smaller reporting company	☐
		Emerging growth company	☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No ☒

Securities registered pursuant to Section 12(b) of the Act:


Title of each class	Trading Symbol	Name of each exchange on which registered
Common stock, par value $0.01 per share	SSNC	The Nasdaq Global Select Market

There were 247,323,277 shares of the registrant’s common stock outstanding as of April 24, 2024.

SS&C TECHNOLOGIES HOLDINGS, INC.

INDEX


		Page Number

PART 1. FINANCIAL INFORMATION

Item 1. Financial Statements (unaudited)		3

Condensed Consolidated Balance Sheets at March 31, 2024 and December 31, 2023		3

Condensed Consolidated Statements of Comprehensive Income for the three months ended March 31, 2024 and 2023		4

Condensed Consolidated Statements of Cash Flows for the three months ended March 31, 2024 and 2023		5

Condensed Consolidated Statements of Stockholders’ Equity for the three months ended March 31, 2024 and 2023		6

Notes to Condensed Consolidated Financial Statements		7

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations		13

Item 3. Quantitative and Qualitative Disclosures About Market Risk		21

Item 4. Controls and Procedures		22

PART II. OTHER INFORMATION

Item 1. Legal Proceedings		22

Item 1A. Risk Factors		22

Item 2. Unregistered Sales of Equity Securities, Use of Proceeds, and Issuer Purchases of Equity Securities		23

Item 6. Exhibits		24

EXHIBIT INDEX		24

SIGNATURE		25

SS&C Technologies Holdings, Inc., or “SS&C Holdings,” is our top-level holding company. SS&C Technologies, Inc., or “SS&C,” is our primary operating company and a wholly-owned subsidiary of SS&C Technologies Holdings, Inc. “We,” “us,” “our” and the “Company” mean SS&C Technologies Holdings, Inc. and its consolidated subsidiaries, including SS&C.

This Quarterly Report on Form 10-Q may contain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. For this purpose, any statements contained herein that are not statements of historical fact may be deemed to be forward-looking statements. Without limiting the foregoing, the words “believes”, “anticipates”, “plans”, “expects”, “estimates”, “projects”, “forecasts”, “may”, “assume”, “intend”, “will”, “continue”, “opportunity”, “predict”, “potential”, “future”, “guarantee”, “likely”, “target”, “indicate”, “would”, “could” and “should” and similar expressions are intended to identify forward-looking statements. The important factors discussed under the caption “Risk Factors” in this Quarterly Report on Form 10-Q and in our Annual Report on Form 10-K for the year ended December 31, 2023, filed with the Securities and Exchange Commission on February 28, 2024, among others, could cause actual results to differ materially from those indicated by forward-looking statements made herein and presented elsewhere by management from time to time. We do not undertake an obligation to update its forward-looking statements to reflect future events or circumstances.

PART I

Item 1. Financial Statements

SS&C TECHNOLOGIES HOLDINGS, INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED BALANCE SHEETS

(In millions, except per share data) (Unaudited)


	March 31,			December 31,
	2024			2023
Assets
Current assets:
Cash and cash equivalents	$	412.5		$	432.2
Funds receivable and funds held on behalf of clients		2,027.0			2,615.6
Accounts receivable, net of allowance for credit losses of $27.4 and $25.1, respectively		879.9			799.4
Contract assets		43.2			36.1
Prepaid expenses and other current assets		142.8			165.8
Restricted cash and cash equivalents		2.2			2.4
Total current assets		3,507.6			4,051.5
Property, plant and equipment, net (Note 2)		300.1			315.3
Operating lease right-of-use assets		213.5			221.4
Investments (Note 3)		183.7			184.7
Unconsolidated affiliates (Note 4)		346.7			345.2
Contract assets		100.2			99.7
Goodwill (Note 5)		8,933.2			8,969.5
Intangible and other assets, net of accumulated amortization of $4,203.6 and $4,063.4, respectively		3,801.8			3,915.2
Total assets	$	17,386.8		$	18,102.5
Liabilities and Equity
Current liabilities:
Current portion of long-term debt (Note 6)	$	50.8		$	51.5
Client funds obligations		2,027.0			2,615.6
Accounts payable		38.3			80.3
Income taxes payable		65.3			22.3
Accrued employee compensation and benefits		168.9			270.2
Interest payable		2.8			29.4
Other accrued expenses		226.5			232.3
Deferred revenues		493.2			470.3
Total current liabilities		3,072.8			3,771.9
Long-term debt, net of current portion (Note 6)		6,593.5			6,668.5
Operating lease liabilities		191.7			199.1
Other long-term liabilities		256.2			248.7
Deferred income taxes		779.9			816.6
Total liabilities		10,894.1			11,704.8
Commitments and contingencies (Note 13)
Stockholders’ equity (Note 7):
Preferred stock, $0.01 par value per share, 5.0 million shares authorized; no shares issued		—			—
Class A non-voting common stock, $0.01 par value per share, 5.0 million shares authorized; no shares issued		—			—
Common stock, $0.01 par value per share, 400.0 million shares authorized; 277.3 million shares and 275.9 million shares issued, respectively, and 247.2 million shares and 246.6 million shares outstanding, respectively		2.8			2.8
Additional paid-in capital		5,468.2			5,371.0
Accumulated other comprehensive loss		(473.9	)		(426.3	)
Retained earnings		3,224.2			3,126.3
Cost of common stock in treasury, 30.1 and 29.3 million shares, respectively		(1,787.1	)		(1,734.2	)
Total SS&C stockholders’ equity		6,434.2			6,339.6
Noncontrolling interest (Note 8)		58.5			58.1
Total equity		6,492.7			6,397.7
Total liabilities and equity	$	17,386.8		$	18,102.5

The accompanying notes are an integral part of these condensed consolidated financial statements.

SS&C TECHNOLOGIES HOLDINGS, INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME

(In millions, except per share data) (Unaudited)


	Three Months Ended March 31,
	2024			2023
Revenues:
Software-enabled services	$	1,187.7		$	1,114.2
License, maintenance and related		247.3			248.5
Total revenues		1,435.0			1,362.7
Cost of revenues:
Software-enabled services		633.8			631.0
License, maintenance and related		94.0			94.7
Total cost of revenues		727.8			725.7
Gross profit		707.2			637.0
Operating expenses:
Selling and marketing		140.9			139.8
Research and development		120.9			118.2
General and administrative		112.5			98.9
Total operating expenses		374.3			356.9
Operating income		332.9			280.1
Interest expense, net		(116.0	)		(111.9	)
Other income, net		6.6			5.4
Equity in earnings of unconsolidated affiliates, net		2.3			5.7
Loss on extinguishment of debt		(1.1	)		(0.6	)
Income before income taxes		224.7			178.7
Provision for income taxes		66.7			52.5
Net income		158.0			126.2
Net income attributable to noncontrolling interest		(0.4	)		(0.2	)
Net income attributable to SS&C common stockholders	$	157.6		$	126.0

Basic earnings per share attributable to SS&C common stockholders	$	0.64		$	0.50
Diluted earnings per share attributable to SS&C common stockholders	$	0.62		$	0.49

Basic weighted-average number of common shares outstanding		247.0			250.4
Diluted weighted-average number of common and common equivalent shares outstanding		253.3			257.0

Net income	$	158.0		$	126.2
Other comprehensive (loss) income, net of tax:
Foreign currency exchange translation adjustment		(47.6	)		42.0
Change in defined benefit pension obligation		—			0.1
Total other comprehensive (loss) income, net of tax		(47.6	)		42.1
Comprehensive income		110.4			168.3
Comprehensive income attributable to noncontrolling interest		(0.4	)		(0.2	)
Comprehensive income attributable to SS&C common stockholders	$	110.0		$	168.1

The accompanying notes are an integral part of these condensed consolidated financial statements.

SS&C TECHNOLOGIES HOLDINGS, INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

(In millions) (Unaudited)


	Three Months Ended March 31,
	2024			2023
Cash flow from operating activities:
Net income	$	158.0		$	126.2
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization		165.5			165.9
Equity in earnings of unconsolidated affiliates, net		(2.3	)		(5.7	)
Distributions received from unconsolidated affiliates		—			15.0
Stock-based compensation expense		45.1			41.9
Net gains on investments		(0.3	)		(1.0	)
Amortization and write-offs of loan origination costs and original issue discounts		3.3			3.5
Loss on extinguishment of debt		1.1			0.6
Loss on sale or disposition of property and equipment		—			6.4
Deferred income taxes		(31.4	)		(30.2	)
Provision for credit losses		5.1			5.0
Changes in operating assets and liabilities, excluding effects from acquisitions:
Accounts receivable		(89.7	)		(35.3	)
Prepaid expenses and other assets		7.9			38.7
Contract assets		(8.6	)		0.1
Accounts payable		(40.6	)		(9.3	)
Accrued expenses and other liabilities		(133.9	)		(155.7	)
Income taxes prepaid and payable		70.1			59.6
Deferred revenue		31.2			29.1
Net cash provided by operating activities		180.5			254.8
Cash flow from investing activities:
Cash paid for business acquisitions, net of cash acquired and asset acquisitions		(0.7	)		—
Additions to property and equipment		(5.8	)		(10.5	)
Proceeds from sale of property and equipment		3.3			—
Additions to capitalized software		(50.0	)		(42.6	)
Proceeds from sales / maturities of investments		0.1			0.9
Collection of other non-current receivables		2.5			2.4
Net cash used in investing activities		(50.6	)		(49.8	)
Cash flow from financing activities:
Cash received from debt borrowings, net of original issue discount		15.0			145.0
Repayments of debt		(94.9	)		(189.6	)
Net decrease in client funds obligations		(690.0	)		(541.9	)
Proceeds from exercise of stock options		53.4			15.3
Withholding taxes paid related to equity award net share settlement		(6.8	)		(0.1	)
Purchases of common stock for treasury		(52.9	)		(133.3	)
Dividends paid on common stock		(59.7	)		(50.7	)
Net cash used in financing activities		(835.9	)		(755.3	)
Effect of exchange rate changes on cash, cash equivalents and restricted cash		(3.8	)		0.9
Net decrease in cash, cash equivalents and restricted cash		(709.8	)		(549.4	)
Cash, cash equivalents and restricted cash, beginning of period		2,998.6			1,337.6
Cash, cash equivalents and restricted cash and cash equivalents, end of period	$	2,288.8		$	788.2


Reconciliation of cash, cash equivalents and restricted cash and cash equivalents:
Cash and cash equivalents	$	412.5		$	433.3
Restricted cash and cash equivalents		2.2			2.5
Restricted cash and cash equivalents included in funds receivable and funds held on behalf of clients		1,874.1			352.4
	$	2,288.8		$	788.2

The accompanying notes are an integral part of these condensed consolidated financial statements.

SS&C TECHNOLOGIES HOLDINGS, INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS’ EQUITY

(In millions) (Unaudited)


	Three Months Ended March 31, 2024
	SS&C Stockholders
	Common Stock
	Number									Accumulated
	of				Additional					Other								Total
	Issued				Paid-in		Retained			Comprehensive			Treasury			Noncontrolling		Stockholders’
	Shares		Amount		Capital		Earnings			Loss			Stock			Interest		Equity
Balance, at December 31, 2023	275.9		$	2.8	$	5,371.0	$	3,126.3		$	(426.3	)	$	(1,734.2	)	$	58.1	$	6,397.7
Net income		—		—		—		157.6			—			—		0.4			158.0
Foreign exchange translation adjustment		—		—		—		—			(47.6	)		—			—		(47.6	)
Stock-based compensation expense		—		—	45.1			—			—			—			—		45.1
Exercise of options, net of withholding taxes	1.4			—	51.9			—			—			—			—		51.9
Cash dividends declared - $0.24 per share		—		—	0.2			(59.7	)		—			—			—		(59.5	)
Purchases of common stock		—		—		—		—			—			(52.9	)		—		(52.9	)
Balance, at March 31, 2024	277.3		$	2.8	$	5,468.2	$	3,224.2		$	(473.9	)	$	(1,787.1	)	$	58.5	$	6,492.7


	Three Months Ended March 31, 2023
	SS&C Stockholders
	Common Stock
	Number									Accumulated
	of				Additional					Other								Total
	Issued				Paid-in		Retained			Comprehensive			Treasury			Noncontrolling		Stockholders’
	Shares		Amount		Capital		Earnings			(Loss) Income			Stock			Interest		Equity
Balance, at December 31, 2022	271.9		$	2.7	$	5,111.6	$	2,740.1		$	(550.1	)	$	(1,260.1	)	$	56.6	$	6,100.8
Net income		—		—		—		126.0			—			—		0.2			126.2
Foreign exchange translation adjustment		—		—		—		—			42.0			—			—		42.0
Defined benefit pension adjustment		—		—		—		—			0.1			—			—		0.1
Stock-based compensation expense		—		—	41.9			—			—			—			—		41.9
Exercise of options, net of withholding taxes	0.4			—	15.2			—			—			—			—		15.2
Cash dividends declared - $0.20 per share		—		—		—		(50.7	)		—			—			—		(50.7	)
Purchases of common stock		—		—		—		—			—			(134.7	)		—		(134.7	)
Balance, at March 31, 2023	272.3		$	2.7	$	5,168.7	$	2,815.4		$	(508.0	)	$	(1,394.8	)	$	56.8	$	6,140.8

The accompanying notes are an integral part of these condensed consolidated financial statements.

SS&C TECHNOLOGIES HOLDINGS, INC. AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Unaudited)

Note 1—Basis of Presentation and Principles of Consolidation

The accompanying financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”). These accounting principles were applied on a basis consistent with those of the audited Consolidated Financial Statements contained in our Annual Report on Form 10-K for the year ended December 31, 2023, filed with the Securities and Exchange Commission (the “SEC”) on February 28, 2024 (the “2023 Form 10-K”). In the opinion of management, the accompanying unaudited Condensed Consolidated Financial Statements contain all adjustments (consisting of only normal recurring adjustments, except as noted elsewhere in the notes to the Condensed Consolidated Financial Statements) necessary for a fair statement of our financial position as of March 31, 2024, the results of our operations for the three months ended March 31, 2024 and 2023, and our cash flows for the three months ended March 31, 2024 and 2023. These statements do not include all of the information and footnotes required by GAAP for annual financial statements. The Condensed Consolidated Financial Statements contained herein should be read in conjunction with the audited Consolidated Financial Statements and footnotes as of and for the year ended December 31, 2023, which were included in the 2023 Form 10-K. The December 31, 2023 Consolidated Balance Sheet data were derived from audited financial statements but do not include all disclosures required by GAAP for annual financial statements. The results of operations for the three months ended March 31, 2024 are not necessarily indicative of the expected results for any subsequent quarters or the full year.

The accompanying unaudited condensed consolidated financial statements include the accounts of SS&C Technologies Holdings, Inc. and its subsidiaries, including a variable interest entity (“VIE”) for which we are the primary beneficiary. All intercompany balances and transactions have been eliminated in consolidation.

Recent Accounting Pronouncements Not Yet Effective

In November 2023, the FASB issued ASU 2023-07, Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures. The standard is applicable to all public entities, including public entities with a single reportable segment, and requires enhanced reportable segment disclosures. The disclosures include significant segment expenses regularly provided to the chief operating decision maker (“CODM”) and included within each reported measure of segment profit or loss. The standard also requires disclosure of the title and position of the CODM as well as how the CODM uses the reported measures of a segment’s profit or loss to assess segment performance and decide how to allocate resources. The new standard is effective for fiscal years beginning after December 15, 2023, and interim periods within fiscal years beginning after December 31, 2024. Early adoption is permitted. We are currently evaluating the potential impact the standard will have on our disclosures.

In December 2023, the FASB issued ASU 2023-09, Improvements to Income Tax Disclosures (Topic 740). The standard requires more enhanced disclosures specifically related to effective tax rate reconciliation and income taxes paid. The new requirements will be effective for fiscal years beginning after December 15, 2024, on a prospective basis. Early adoption and retrospective application are permitted. We are currently evaluating the potential impact the standard will have on our income tax disclosures.

Note 2—Property, Plant and Equipment, net

Property, plant and equipment and the related accumulated depreciation are as follows (in millions):


	March 31,			December 31,
	2024			2023
Land	$	37.5		$	37.7
Building and improvements		266.1			265.5
Equipment, furniture, and fixtures		525.2			525.7
		828.8			828.9
Less: accumulated depreciation		(528.7	)		(513.6	)
Total property, plant and equipment, net	$	300.1		$	315.3

Depreciation expense for the three months ended March 31, 2024 and 2023 was $17.9 million and $19.0 million, respectively. As of March 31, 2024 and December 31, 2023, assets held for sale were $5.9 million and $9.0 million, respectively, and are presented in prepaid expenses and other current assets in our condensed consolidated balance sheet. Unpaid property, plant and equipment additions of $1.0 million and $2.9 million are included in accounts payable and other accrued expenses as of March 31, 2024 and December 31, 2023, respectively, in our condensed consolidated balance sheet.

Note 3—Investments

Investments are as follows (in millions):


	March 31,		December 31,
	2024		2023
Non-marketable equity securities	$	124.0	$	124.0
Seed capital investments		26.3		26.1
Marketable equity securities		22.5		23.1
Partnership interests in private equity funds		10.9		11.5
Total investments	$	183.7	$	184.7

There were no realized gains or losses for our equity securities in the three months ended March 31, 2024 and 2023. Unrealized gains for our equity securities are as follows (in millions):


	Three Months Ended March 31,
	2024		2023
Unrealized gains on equity securities held as of the end of the period	$	0.9	$	2.3

Fair Value Measurement

Authoritative accounting guidance on fair value measurements establishes a three-tier fair value hierarchy, which prioritizes the inputs used in measuring fair value. These tiers include: Level 1, defined as observable inputs such as quoted prices in active markets; Level 2, defined as inputs other than quoted prices in active markets that are either directly or indirectly observable; and Level 3, defined as unobservable inputs for which little or no market data exists, therefore requiring an entity to develop its own assumptions.

As of March 31, 2024 and December 31, 2023, we held certain investment assets and certain liabilities that are required to be measured at fair value on a recurring basis. These investments include money market funds and marketable equity securities where fair value is determined using quoted prices in active markets. Accordingly, the fair value measurements of these investments have been classified as Level 1 in the tables below. Investments for which we elected net asset value as a practical expedient for fair value and investments measured using the fair value measurement alternative are excluded from the tables below. Fair value for deferred compensation liabilities that are credited with deemed gains or losses of the underlying hypothetical investments, primarily equity securities, have been classified as Level 1 in the tables below.

The following tables present assets and liabilities measured at fair value on a recurring basis (in millions):


				Fair Value Measurements at Reporting Date Using
	March 31, 2024			Quoted prices in Active Markets for Identical Assets (Level 1)			Significant Other Observable Inputs (Level 2)		Significant Unobservable Inputs (Level 3)
Money market funds (1)	$	1,781.6		$	1,781.6		$	—	$	—
Seed capital investments (2)		26.3			26.3			—		—
Marketable equity securities (2)		22.5			22.5			—		—
Deferred compensation liabilities (3)		(12.3	)		(12.3	)		—		—
Total	$	1,818.1		$	1,818.1		$	—	$	—


				Fair Value Measurements at Reporting Date Using
	December 31, 2023			Quoted prices in Active Markets for Identical Assets (Level 1)			Significant Other Observable Inputs (Level 2)		Significant Unobservable Inputs (Level 3)
Money market funds (1)	$	2,212.6		$	2,212.6		$	—	$	—
Seed capital investments (2)		26.1			26.1			—		—
Marketable equity securities (2)		23.1			23.1			—		—
Deferred compensation liabilities (3)		(11.7	)		(11.7	)		—		—
Total	$	2,250.1		$	2,250.1		$	—	$	—

(1)

As of March 31, 2024, included $112.3 million of cash and cash equivalents, $1.6 million of restricted cash and $1,667.7 million of funds receivable and funds held on behalf of clients on the Condensed Consolidated Balance Sheet. As of December 31, 2023, included $131.7 million of cash and cash equivalents, $1.8 million of restricted cash and $2,079.1 million of funds receivable and funds held on behalf of clients on the Condensed Consolidated Balance Sheet.

(2)

Included in Investments on the Condensed Consolidated Balance Sheet.

(3)

Included in Other long-term liabilities on the Condensed Consolidated Balance Sheet.

We have partnership interests in various private equity funds that are not included in the tables above. Our investments in private equity funds were $10.9 million and $11.5 million at March 31, 2024 and December 31, 2023, respectively, of which $9.3 million and $9.2 million, respectively, were measured using net asset value as a practical expedient for fair value and $1.6 million and $2.3 million, respectively, were accounted for under the equity method of accounting. The investments in private equity funds represent underlying investments in domestic and international markets across various industry sectors.

Generally, our investments in private equity funds are non-transferable or are subject to long holding periods, and withdrawals from the private equity firm partnerships are typically not permitted. The maximum risk of loss related to our private equity fund investments is limited to the carrying value of its investments in the entities.

Note 4—Unconsolidated Affiliates

Investments in unconsolidated affiliates are as follows (in millions):


		March 31, 2024				December 31, 2023
	Ownership Percentage	Carrying Value		Excess carrying value of investment over proportionate share of net assets		Carrying Value		Excess carrying value of investment over proportionate share of net assets
Orbit Private Investments L.P.	9.8%	$	212.9	$	—	$	211.6	$	—
International Financial Data Services L.P.	50.0%		68.9		30.6		68.3		31.4
Broadway Square Partners, LLP	50.0%		53.1		29.3		53.4		29.5
Pershing Road Development Company, LLC	50.0%		9.9		54.8		10.0		55.4
Other unconsolidated affiliates			1.9		—		1.9		—
Total		$	346.7	$	114.7	$	345.2	$	116.3

Investments in unconsolidated affiliates are accounted for under the equity method of accounting. We record our proportionate share of the results of the unconsolidated affiliates and amortization expense related to basis differences in Equity in earnings of unconsolidated affiliates, net on the Condensed Consolidated Statements of Comprehensive Income.

Equity in earnings of unconsolidated affiliates, net are as follows (in millions):


	Three Months Ended March 31,
	2024			2023

Orbit Private Investments L.P.	$	1.2		$	4.8
International Financial Data Services L.P.		1.5			1.1
Pershing Road Development Company, LLC		(0.1	)		(0.2	)
Broadway Square Partners, LLP		(0.3	)		0.1
Other unconsolidated affiliates		—			(0.1	)
Total	$	2.3		$	5.7

Note 5—Goodwill

The change in carrying value of goodwill as of and for the three months ended March 31, 2024 is as follows (in millions):


Balance at December 31, 2023	$	8,969.5
Adjustments to prior acquisitions		0.1
Effect of foreign currency translation		(36.4	)
Balance at March 31, 2024	$	8,933.2

Note 6—Debt

At March 31, 2024 and December 31, 2023, debt consisted of the following (in millions):


	March 31,			December 31,
	2024			2023
Senior secured credit facilities, weighted-average interest rate of 7.32% and 7.35%, respectively	$	4,675.2		$	4,755.1
5.5% senior notes due 2027		2,000.0			2,000.0
Unamortized original issue discount and debt issuance costs		(30.9	)		(35.1	)
		6,644.3			6,720.0
Less: current portion of long-term debt		50.8			51.5
Long-term debt	$	6,593.5		$	6,668.5

The table below provides a summary of the key terms of our Senior Secured Credit Facilities and Senior Notes:


	Amount Outstanding at March 31, 2024		Maturity	Scheduled Quarterly
	(in millions)		Date	Payments Required
Senior Secured Credit Facilities
Term Loan B-3	$	994.4	April 16, 2025	0.25%
Term Loan B-4		938.9	April 16, 2025	0.25%
Term Loan B-5		1,582.0	April 16, 2025	0.25%
Term Loan B-6		394.0	March 22, 2029	0.25%
Term Loan B-7		765.9	March 22, 2029	0.25%
Revolving Credit Facility		—	December 28, 2027	None
Senior Notes		2,000.0	September 30, 2027	None

Fair Value of Debt

The carrying amounts and fair values of financial instruments are as follows (in millions):


	March 31, 2024				December 31, 2023
	Carrying		Fair		Carrying		Fair
	Amount		Value		Amount		Value
Financial liabilities:
Senior secured credit facilities	$	4,646.9	$	4,688.4	$	4,722.7	$	4,774.4
5.5% senior notes due 2027		1,997.4		1,958.9		1,997.3		1,974.0

The above fair values, which are Level 2 liabilities, were computed based on comparable quoted market prices. The fair values of cash, accounts receivable, net, short-term borrowings, and accounts payable approximate the carrying amounts due to the short-term maturities of these instruments.

Note 7—Stockholders’ Equity

Stock repurchase program

In both July 2022 and July 2023, our Board of Directors authorized a stock repurchase program, which enabled us to repurchase up to $1 billion in the aggregate of our outstanding common stock on the open market or in privately negotiated transactions until the one-year anniversary of the Board’s authorization, unless earlier terminated by the Board. During the three months ended March 31, 2024 and 2023, we repurchased 0.8 million and 2.3 million shares, respectively, of common stock for approximately $52.9 million and $134.7 million, respectively, which includes a 1% excise tax on share repurchases. We use the cost method to account for treasury stock purchases. Under the cost method, the price paid for the stock is charged to the treasury stock account.

Dividends

We paid a quarterly cash dividend of $0.24 per share of common stock in March 2024 totaling $59.7 million. We paid a quarterly cash dividend of $0.20 per share of common stock in March 2023 totaling $50.7 million.

Accumulated Other Comprehensive Loss

Accumulated other comprehensive loss balances, net of tax, consist of the following (in millions):


	Foreign Currency Translation			Defined Benefit Obligation			Accumulated Other Comprehensive Loss
Balance, December 31, 2023	$	(424.5	)	$	(1.8	)	$	(426.3	)
Net current period other comprehensive loss		(47.6	)		—			(47.6	)
Balance, March 31, 2024	$	(472.1	)	$	(1.8	)	$	(473.9	)

Adjustments to accumulated other comprehensive loss are as follows (in millions):


	Three Months Ended March 31,
	2024					2023
	Pretax			Tax Effect		Pretax		Tax Effect
Defined Benefit Pension
Unrealized net gains on defined benefit pension plan	$	—		$	—	$	—	$	0.1
Foreign Currency Translation
Current period translation adjustments		(48.6	)		1.0		44.2		(2.2	)
Total other comprehensive (loss) income	$	(48.6	)	$	1.0	$	44.2	$	(2.1	)

Note 8—Variable Interest Entity

In July 2021, we entered into an agreement whereby we obtained an 80.2% interest in DomaniRx, LLC (“DomaniRx”), a variable interest entity under GAAP. We have the power to direct the majority of the activities of DomaniRx that most significantly impact its economic performance, the obligation to absorb losses and the right to receive benefits from DomaniRx. Accordingly, we determined that we are the primary beneficiary of DomaniRx and consolidate its results.

The carrying value of the assets and liabilities associated with DomaniRx included in our condensed consolidated balance sheet at March 31, 2024 and December 31, 2023, which are limited for use in its operations and do not have recourse against our general credit or our senior secured credit facilities, are as follows:


	March 31,		December 31,
	2024		2023
Assets:
Cash and cash equivalents	$	95.1	$	100.2
Intangible assets		200.6		193.3
Other assets		2.3		3.2
Liabilities:
Other liabilities		3.3		3.9

Note 9—Revenues

We generate revenues primarily through our software-enabled services. Our software-enabled services are generally provided under contracts with initial terms of one to five years that require monthly or quarterly payments and are subject to automatic annual renewal at the end of the initial term unless terminated by either party. We also generate revenues by licensing our software to clients through either perpetual or term licenses and by selling maintenance services. We classify license revenues related to sales-based royalty arrangements as term license revenue. Maintenance services are generally provided under annually renewable contracts. Our pricing typically scales as a function of our clients’ assets under management, the complexity of asset classes managed, the volume of transactions and the level of service the client requires. Revenues from professional services consist mostly of services provided on a time and materials basis.

Deferred revenues primarily represent unrecognized fees billed or collected for maintenance and professional services. Deferred revenues are recognized as (or when) we perform under the contract. Deferred revenues are recorded on a net basis with contract assets at the contract level. Accordingly, as of March 31, 2024 and December 31, 2023, approximately $68.5 million and $72.0 million, respectively, of deferred revenue is presented net within contract assets arising from the same contracts. The amount of revenues recognized in the period that was included in the opening deferred revenues balance was $158.2 million for the three months ended March 31, 2024.

As of March 31, 2024, revenue of approximately $1,005.2 million is expected to be recognized from remaining performance obligations for license, maintenance and related revenues, of which $496.2 million is expected to be recognized over the next twelve months.

We record revenue net of any taxes assessed by governmental authorities.

Revenue Disaggregation

The following table disaggregates our revenues by geography (in millions):


	Three Months Ended March 31,
	2024		2023
United States	$	992.3	$	954.9
United Kingdom		165.5		155.9
Europe (excluding United Kingdom), Middle East and Africa		115.9		105.4
Asia-Pacific and Japan		73.3		68.0
Canada		59.6		55.5
Americas, excluding United States and Canada		28.4		23.0
Total	$	1,435.0	$	1,362.7

The following table disaggregates our revenues by source (in millions):


	Three Months Ended March 31,
	2024		2023
Software-enabled services	$	1,187.7	$	1,114.2
Maintenance and term licenses		218.8		213.3
Professional services		23.8		27.7
Perpetual licenses		4.7		7.5
Total	$	1,435.0	$	1,362.7

Note 10—Stock Based Compensation

Stock options, SARs, PSUs and RSUs

The amount of stock-based compensation expense recognized in our Condensed Consolidated Statements of Comprehensive Income for the three months ended March 31, 2024 and 2023 was as follows (in millions):


	Three Months Ended March 31,
Condensed Consolidated Statements of Comprehensive Income Classification	2024		2023
Cost of software-enabled services	$	15.4	$	15.5
Cost of license, maintenance and other related		1.6		1.8
Total cost of revenues		17.0		17.3
Selling and marketing		7.7		7.9
Research and development		6.2		5.4
General and administrative		14.2		11.3
Total operating expenses		28.1		24.6
Total stock-based compensation expense	$	45.1	$	41.9

The stock-based compensation expense related to performance awards is adjusted for changes in our assessment of the performance target level that is probable of being achieved and the number of performance-based equity awards expected to vest. In December 2021, we granted performance-based stock options (“PSOs”) for which the 3-year performance period ends in December

2024. If the threshold level of performance is not achieved for these PSOs, $42.7 million of previously recorded stock-based compensation expense will be reversed.

The following table summarizes stock option and stock appreciation rights (“SARs”) activity, as well as performance stock units (“PSUs”) and restricted stock units (“RSUs”) activity, for the three months ended March 31, 2024 (shares in millions):


	Stock Options and SARs			PSUs and RSUs
Outstanding at December 31, 2023		38.8			3.5
Granted		1.8			3.4
Cancelled/forfeited		(0.5	)		(0.8	)
Exercised		(1.3	)		—
Vested		—			(0.3	)
Outstanding at March 31, 2024		38.8			5.8

Note 11—Income Taxes

The effective tax rate was 29.7% and 29.4% for the three months ended March 31, 2024 and 2023, respectively. The change in the effective tax rate for the three months ended March 31, 2024 compared to the prior year was primarily due to a proportionate change in the composition of income before income taxes from foreign and domestic tax jurisdictions.

Note 12—Earnings per Share

The following table sets forth the computation of basic and diluted EPS (in millions, except per share amounts):


	Three Months Ended March 31,
	2024		2023
Net income attributable to SS&C common stockholders	$	157.6	$	126.0

Shares attributable to SS&C:
Weighted-average common shares outstanding – used in calculation of basic EPS		247.0		250.4
Weighted-average common stock equivalents – stock options and restricted shares		6.3		6.6
Weighted-average common and common equivalent shares outstanding – used in calculation of diluted EPS		253.3		257.0

Earnings per share attributable to SS&C common stockholders – Basic	$	0.64	$	0.50
Earnings per share attributable to SS&C common stockholders – Diluted	$	0.62	$	0.49

Weighted-average stock options, SARs, RSUs and PSUs representing 18.4 million and 25.0 million shares were outstanding for the three months ended March 31, 2024 and 2023, respectively, but were not included in the computation of diluted EPS because the effect of including them would be anti-dilutive.

Note 13—Commitments and Contingencies

From time to time, we are subject to legal proceedings and claims. In our opinion, we are not involved in any litigation or proceedings that would have a material adverse effect on us or our business.

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations

This Management’s Discussion and Analysis of Financial Condition and Results of Operations, or MD&A, is intended to provide readers of our Condensed Consolidated Financial Statements with the perspectives of management. It presents, in narrative form, information regarding our financial condition, results of operations, liquidity and certain other factors that may affect our future results. It should be read in conjunction with our 2023 Form 10-K and the Condensed Consolidated Financial Statements included in this Form 10-Q. We use the term organic to refer to the businesses and operations that are included in the comparable prior year period on a constant currency basis. Organic excludes the impact of any business which we acquired for the time period which would impact the comparable prior year period.

Ongoing macroeconomic conditions, such as increases in interest rates, inflation and changes in foreign currency exchange rates, could have impacts on our results that are uncertain and, in many respects, outside our control. The situations remain dynamic and subject to rapid and possibly material change, which ultimately could result in material negative effects on our business and

results of operations. We will continue to evaluate the nature and extent of the potential impacts to our business, consolidated results of operations, liquidity and capital resources.

Critical Accounting Policies

Certain of our accounting policies require the application of significant judgment by our management, and such judgments are reflected in the amounts reported in our Condensed Consolidated Financial Statements. In applying these policies, our management uses its judgment to determine the appropriate assumptions to be used in the determination of estimates. Those estimates are based on our historical experience, terms of existing contracts, management’s observation of trends in the industry, information provided by our clients and information available from other outside sources, as appropriate. Actual results may differ significantly from the estimates contained in our Condensed Consolidated Financial Statements. There have been no material changes to our critical accounting estimates and assumptions or the judgments affecting the application of those estimates and assumptions since the filing of our 2023 Form 10-K. Our critical accounting policies are described in the 2023 Form 10-K and include:

•

Investments

•

Intangible Assets and Goodwill

•

Software Capitalization

•

Revenue Recognition

•

Stock-based Compensation

•

Income Taxes

Results of Operations

Revenues

We derive our revenues from two sources: software-enabled services revenues and license, maintenance and related revenues. As a general matter, fluctuations in our software-enabled services revenues are attributable to the number of new software-enabled services clients as well as total assets under management in our clients’ portfolios and the number of outsourced transactions provided to our existing clients. Software-enabled services revenues also fluctuate as a result of reimbursements received for “out-of-pocket” expenses, such as postage and telecommunications charges, which are recorded as revenues on an accrual basis. Because these additional revenues are offset by the reimbursable expenses incurred, there is no impact on gross profit, operating income and net income, however the reimbursements billed and expenses incurred can lead to fluctuations in revenues, cost of revenues and gross margin percentage each period. License, maintenance and related revenues consist primarily of term and perpetual license fees, maintenance fees and professional services. Maintenance revenues vary based on customer retention and on the annual increases in fees, which are generally tied to the consumer price index. License and professional services revenues tend to fluctuate based on the number of new licensing clients, the timing and terms of contract renewals and demand for consulting services.

Our results of operations below include the results of our recent acquisition from the date which it was acquired. The Iress Managed Funds Administration Business (“2023 acquisition”) was acquired in October 2023.

The following table sets forth the percentage of our total revenues represented by each of the following sources of revenues for the periods indicated:


	Three Months Ended March 31,
	2024			2023
Software-enabled services		82.8	%		81.8	%
License, maintenance and related		17.2	%		18.2	%
Total revenues		100.0	%		100.0	%

The following table sets forth revenues (dollars in millions) and percent change in revenues for the periods indicated:


	Three Months Ended March 31,				Percent Change from Prior Period
	2024		2023
Software-enabled services	$	1,187.7	$	1,114.2		6.6	%
License, maintenance and related		247.3		248.5		(0.5	)%
Total revenues	$	1,435.0	$	1,362.7		5.3	%

Three Months Ended March 31, 2024 and 2023. Our revenues increased $72.3 million, or 5.3%, primarily due to an increase of $63.8 million in organic revenues driven by strength in the SS&C GlobeOp fund administration and virtual data room services businesses. Our revenues also increased due to the favorable impact from foreign currency translation of $5.6 million and the 2023 acquisition, which contributed $2.9 million in revenues. Software-enabled services revenues increased $73.5 million, or 6.6%, primarily due to an increase in organic revenues of $65.5 million and the favorable impact from foreign currency translation of $5.4 million, as well as the acquisition, which added $2.6 million in revenues. License, maintenance and related revenues decreased $1.2 million, or 0.5%, primarily due to a decrease in organic revenues of $1.7 million. Those decreases were partially offset by the acquisition, which added $0.3 million in revenues, and the favorable impact from foreign currency translation of $0.2 million.

Cost of Revenues

Cost of software-enabled services revenues consists primarily of costs related to personnel utilized in providing our software-enabled services and amortization of intangible assets. Cost of license, maintenance and other related revenues consists primarily of the costs related to personnel utilized in servicing our maintenance contracts and to provide implementation, conversion and training services to our software licensees, as well as system integration and custom programming consulting services and amortization of intangible assets.

The following tables set forth each of the following cost of revenues as a percentage of their respective revenue source for the periods indicated:


	Three Months Ended March 31,
	2024			2023
Cost of software-enabled services		53.4	%		56.6	%
Cost of license, maintenance and related		38.0	%		38.1	%
Total cost of revenues		50.7	%		53.3	%
Gross margin percentage		49.3	%		46.7	%

The following table sets forth cost of revenues (dollars in millions) and percent change in cost of revenues for the periods indicated:


	Three Months Ended March 31,				Percent Change from Prior Period
	2024		2023
Cost of software-enabled services	$	633.8	$	631.0		0.4	%
Cost of license, maintenance and related		94.0		94.7		(0.7	)%
Total cost of revenues	$	727.8	$	725.7		0.3	%

Three Months Ended March 31, 2024 and 2023. Our total cost of revenues increased by $2.1 million, or 0.3%, due to the 2023 acquisition, which added costs of $4.7 million, and the unfavorable impact from foreign currency translation, which increased costs by $3.1 million. These increases were partially offset by a $5.7 million decrease in organic costs. Our organic cost decrease reflects continued efficiency improvement efforts in delivering client service. Cost of software-enabled services revenues increased $2.8 million, or 0.4%, primarily due to the 2023 acquisition, which added $4.7 million in costs, and the unfavorable impact from foreign currency translation of $2.6 million. These increases were partially offset by a $4.5 million decrease in organic costs. Cost of license, maintenance and related revenues decreased $0.7 million, or 0.7%, primarily due to a $1.2 million decrease in organic costs, partially offset by the unfavorable impact from foreign currency translation of $0.5 million.

Operating Expenses

Selling and marketing expenses consist primarily of the personnel costs associated with the selling and marketing of our products, including salaries, commissions and travel and entertainment. Such expenses also include amortization of intangible assets, the cost of branch sales offices, trade shows and marketing and promotional materials. Research and development expenses consist primarily of personnel costs attributable to the enhancement of existing products and the development of new software products. General and administrative expenses consist primarily of personnel costs related to management, accounting and finance, information management, human resources and administration and associated overhead costs, as well as fees for professional services.

The following table sets forth the percentage of our total revenues represented by each of the following operating expenses for the periods indicated:


	Three Months Ended March 31,
	2024			2023
Selling and marketing		9.8	%		10.3	%
Research and development		8.4	%		8.7	%
General and administrative		7.8	%		7.3	%
Total operating expenses		26.0	%		26.3	%

The following table sets forth operating expenses (dollars in millions) and percent change in operating expenses for the periods indicated:


	Three Months Ended March 31,				Percent Change from Prior Period
	2024		2023
Selling and marketing	$	140.9	$	139.8		0.8	%
Research and development		120.9		118.2		2.3	%
General and administrative		112.5		98.9		13.8	%
Total operating expenses	$	374.3	$	356.9		4.9	%

Three Months Ended March 31, 2024 and 2023. Operating expenses increased $17.4 million, or 4.9%, due to an increase of $15.1 million in organic operating expenses, the unfavorable impact from foreign currency translation of $1.8 million and the 2023 acquisition, which added $0.5 million in expenses. Total operating expenses, excluding the impact of acquisitions and foreign currency translation, primarily increased due to shifting resources to support organic growth.

Comparison of the Three Months Ended March 31, 2024 and 2023 for Interest, Taxes and Other

Interest expense, net. Net interest expense totaled $116.0 million for the three months ended March 31, 2024 compared to $111.9 million for the three months ended March 31, 2023. The increase in interest expense, net for 2024 as compared to 2023, is due to a higher average interest rate on debt. We had an average interest rate of 6.86% and 6.21%, respectively, for the three months ended March 31, 2024 and 2023.

Other income, net. Other income, net was $6.6 million for the three months ended March 31, 2024 compared to $5.4 million for the three months ended March 31, 2023. For the three months ended March 31, 2024, other income, consisted primarily of dividend income of $10.5 million, partially offset by foreign currency translation losses of $4.7 million. For the three months ended March 31, 2023, other income, net consisted primarily of dividend income of $10.2 million, partially offset by losses of $6.1 million related to the fair value adjustments on assets held for sale.

Equity in earnings of unconsolidated affiliates, net. Equity in earnings of unconsolidated affiliates, net totaled $2.3 million and $5.7 million for the three months ended March 31, 2024 and 2023. Our equity in earnings of unconsolidated affiliates, net in 2023 included a $4.8 million adjustment to increase the carrying value of one of our investments.

Provision for income taxes. The following table sets forth the provision for income taxes (dollars in millions) and effective tax rates for the periods indicated:


	Three Months Ended March 31,
	2024			2023
Provision for income taxes	$	66.7		$	52.5
Effective tax rate		29.7	%		29.4	%

Our effective tax rates for the three months ended March 31, 2024 and 2023 differ from the statutory rate of 21.0% primarily due to the composition of income before income taxes from foreign and domestic tax jurisdictions, foreign income that is being taxed in the U.S. offset by foreign tax credits that are being limited and the recognition of windfall tax benefits from stock awards. The change in the effective tax rate for the three months ended March 31, 2024 compared to the prior year was primarily due to a proportionate change in the composition of income before income taxes from foreign and domestic tax jurisdictions. While we have income from multiple foreign sources, the majority of our non-U.S. operations are in the United Kingdom and India. We anticipate the statutory tax rates in 2024 to be 25.0% in the United Kingdom and approximately 28.0% in India. A future change in the composition of income before income taxes from foreign and domestic tax jurisdictions could impact our periodic effective tax rate.

On August 16, 2022, the Inflation Reduction Act was signed into law, which includes a 15% corporate alternative minimum tax and a 1% excise tax on stock repurchases. The provisions were effective January 1, 2023 and were immaterial to our financial results, financial position and cash flows. The 1% excise tax on share repurchases is included as a cost to acquire treasury stock.

In 2021, the OECD (“Organisation for Economic Co-operation and Development”)/G20 Inclusive Framework on Base Erosion and Profit Shifting released Model Global Anti-Base Erosion rules under Pillar Two. Further guidance has been released throughout 2022 and 2023. Certain aspects of Pillar Two are effective January 1, 2024 and other aspects are effective January 1, 2025. Many non-U.S. tax jurisdictions in which we operate have either recently enacted legislation or are in the process of enacting legislation to adopt certain components of the Pillar Two Model Rules beginning in 2024 or in future years. We do not expect the provisions effective in 2024 to materially impact our financial results, financial position and cash flows.

Liquidity and Capital Resources

Our principal cash requirements are to finance the costs of our operations pending the billing and collection of client receivables, to fund payments with respect to our indebtedness, to invest in research and development, to acquire complementary businesses or assets, to repurchase shares of our common stock and to pay dividends on our common stock.

We intend to refinance the $3,515.3 million Term Loans B-3, B-4 and B-5, which are due April 16, 2025, in the near term. However, there can be no assurance that we will be able to obtain such financing on acceptable terms, or at all. Provided that we do obtain such financing, we expect our cash on hand, cash flows from operations and cash available under our Credit Agreement to provide sufficient liquidity to fund our current obligations, projected working capital requirements and capital spending for at least the next twelve months.

Client funds obligations include our transfer agency client balances invested overnight as well as our contractual obligations to remit funds to satisfy client pharmacy claim obligations and are recorded on the Condensed Consolidated Balance Sheet when incurred, generally after a claim has been processed by us. Our contractual obligations to remit funds to satisfy client obligations are primarily sourced by funds held on behalf of clients. We had $2,027.0 million of client funds obligations at March 31, 2024.

Cash flows from operating, investing and financing activities, as reflected in our Condensed Consolidated Statements of Cash Flows, are summarized in the following table (in millions):


	Three Months Ended March 31,
Net cash, cash equivalents and restricted cash provided by (used in):	2024			2023			Change From Prior Year
Operating activities	$	180.5		$	254.8		$	(74.3	)
Investing activities		(50.6	)		(49.8	)		(0.8	)
Financing activities		(835.9	)		(755.3	)		(80.6	)
Effect of exchange rate changes on cash, cash equivalents and restricted cash		(3.8	)		0.9			(4.7	)
Net decrease in cash, cash equivalents and restricted cash	$	(709.8	)	$	(549.4	)	$	(160.4	)

Net cash provided by operating activities was $180.5 million for the three months ended March 31, 2024. Cash provided by operating activities primarily resulted from net income of $158.0 million adjusted for non-cash items of $186.1 million, partially offset by changes in our working capital accounts totaling $163.6 million. The changes in our working capital accounts were driven by decreases in accrued expenses, an increase in accounts receivable and a decrease in accounts payable, partially offset by an increase in deferred revenue and change in income taxes prepaid and payable. The change in income taxes prepaid and payable is primarily driven by the timing of tax payments.

Investing activities used net cash of $50.6 million for the three months ended March 31, 2024, primarily related to $50.0 million in capitalized software development costs and $5.8 million in capital expenditures, partially offset by proceeds from the sale of property and equipment of $3.3 million and the collection of other non-current receivables of $2.5 million.

Financing activities used net cash of $835.9 million for the three months ended March 31, 2024, primarily representing a net decrease in client fund obligations of $690.0 million, $79.9 million of net debt repayments, $59.7 million in quarterly dividends paid and $52.9 million of purchases of common stock for treasury. These expenditures were partially offset by proceeds of $53.4 million from stock option exercises.

We have made a permanent reinvestment determination in certain non-U.S. operations that have historically generated positive operating cash flows. At March 31, 2024, we held approximately $225.2 million in cash and cash equivalents at non-U.S. subsidiaries where we had made such a determination and in turn no provision for income taxes had been made. At March 31, 2024, we held approximately $111.2 million in cash that was available to our foreign borrowers under our senior secured credit facility and will be used to facilitate debt servicing of those entities.

Off-Balance Sheet Arrangements

We have no off-balance sheet arrangements that have or are reasonably likely to have a current or future effect on our financial condition, changes in financial condition, revenues or expenses, results of operations, liquidity, capital expenditures or capital resources that is material to investors.

Senior Secured Credit Facilities and Senior Notes

The table below provides a summary of the key terms of our Senior Secured Credit Facilities and Senior Notes:


	Amount Outstanding at March 31, 2024		Maturity	Scheduled Quarterly
	(in millions)		Date	Payments Required
Senior Secured Credit Facilities
Term Loan B-3	$	994.4	April 16, 2025	0.25%
Term Loan B-4		938.9	April 16, 2025	0.25%
Term Loan B-5		1,582.0	April 16, 2025	0.25%
Term Loan B-6		394.0	March 22, 2029	0.25%
Term Loan B-7		765.9	March 22, 2029	0.25%
Revolving Credit Facility		—	December 28, 2027	None
Senior Notes		2,000.0	September 30, 2027	None

The senior secured credit facility has a revolving credit facility available for borrowings by SS&C with $600.0 million in available commitments (“Revolving Credit Facility”), of which $596.2 million was available as of March 31, 2024. The Revolving Credit Facility also contains a $75.0 million letter of credit sub-facility, of which $3.8 million was utilized as of March 31, 2024.

Our obligations under the Term Loans are guaranteed by (i) our existing and future U.S. wholly-owned restricted subsidiaries, in the case of the Term B-3 Loan, Term B-5 Loan, Term B-6 Loan and the Revolving Credit Facility and (ii) our existing and future wholly-owned restricted subsidiaries, in the case of the Term B-4 Loan and Term B-7 Loan.

The obligations of the U.S. loan parties under the amended senior secured credit facility are secured by substantially all of the assets of such persons (subject to customary exceptions and limitations), including a pledge of all of the capital stock of substantially all of the U.S. wholly-owned restricted subsidiaries of such persons (with customary exceptions and limitations) and 65% of the capital stock of certain foreign restricted subsidiaries of such persons (with customary exceptions and limitations). All obligations of the non-U.S. loan parties under the amended senior secured credit facility are secured by substantially all of our and the other guarantors’ assets (subject to customary exceptions and limitations), including a pledge of all of the capital stock of substantially all of our wholly-owned restricted subsidiaries (with customary exceptions and limitations).

The amended senior secured credit facility includes negative covenants that, among other things and subject to certain thresholds and exceptions, limit our ability and the ability of our restricted subsidiaries to incur debt or liens, make investments (including in the form of loans and acquisitions), merge, liquidate or dissolve, sell property and assets, including capital stock of our subsidiaries, pay dividends on our capital stock or redeem, repurchase or retire our capital stock, alter the business we conduct, amend, prepay, redeem or purchase subordinated debt, or engage in transactions with our affiliates. The amended senior secured credit facility also contains customary representations and warranties, affirmative covenants and events of default, subject to customary thresholds and exceptions. In addition, the amended senior secured credit facility contains a financial covenant for the benefit of the Revolving Credit Facility requiring us to maintain a minimum consolidated net secured leverage ratio. In addition, under the amended senior secured credit facility, certain defaults under agreements governing other material indebtedness could result in an event of default under the amended senior secured credit facility, in which case the lenders could elect to accelerate payments under the amended senior secured credit facility and terminate any commitments they have to provide future borrowings. As of March 31, 2024, we were in compliance with all financial and non-financial covenants.

The Senior Notes are guaranteed, jointly and severally, by SS&C Holdings and all of its existing and future domestic restricted subsidiaries that guarantee our existing senior secured credit facilities or certain other indebtedness. The Senior Notes are unsecured

senior obligations that are equal in right of payment to all of our existing and future senior unsecured indebtedness. Interest on the Senior Notes is payable on March 30 and September 30 of each year.

At any time and from time to time, we may, at our option, redeem some or all of the Senior Notes, in whole or in part, at the redemption prices set forth in the following table, expressed as a percentage of the principal amount, plus accrued and unpaid interest to the redemption date:


Redemption Date	Price
On or after March 30, 2024		101.375	%
March 30, 2025 and thereafter		100.000	%

We may also, from time to time in our sole discretion, purchase, redeem, or retire any outstanding Senior Notes, through tender offers, in privately negotiated or open market transactions, or otherwise.

The indenture governing the Senior Notes contains a number of covenants that restrict, subject to certain thresholds and exceptions, our ability and the ability of our domestic restricted subsidiaries to incur debt or liens, make certain investments, pay dividends, dispose of certain assets, or enter into transactions with its affiliates. Any event of default under the amended senior secured credit facility that leads to an acceleration of those amounts due also results in a default under the indenture governing the Senior Notes.

Covenant Compliance

Under the Revolving Credit Facility portion of the amended senior secured credit facility, we are required to satisfy and maintain a specified financial ratio at the end of each fiscal quarter if the sum of (i) outstanding amount of all loans under the Revolving Credit Facility and (ii) all non-cash collateralized letters of credit issued under the Revolving Credit Facility in excess of $20 million is equal to or greater than 30% of the total commitments under the Revolving Credit Facility. Our ability to meet this financial ratio can be affected by events beyond our control, and we cannot assure you that we will meet this ratio. Any breach of this covenant could result in an event of default under the amended senior secured credit facility. Upon the occurrence of any event of default under the amended senior secured credit facility, the lenders could elect to declare all amounts outstanding under the amended senior secured credit facility to be immediately due and payable and terminate all commitments to extend further credit. Any default and subsequent acceleration of payments under the amended senior secured credit facility would have a material adverse effect on our results of operations, financial position and cash flows. Additionally, under the amended senior secured credit facility, our ability to engage in activities such as incurring additional indebtedness, making investments and paying dividends is also tied to baskets and ratios based on Consolidated EBITDA.

Consolidated EBITDA is a non-GAAP financial measure used in key financial covenants contained in the amended senior secured credit facility, which is the material facility supporting our capital structure and providing liquidity to our business. Consolidated EBITDA is defined as earnings before interest, taxes, depreciation and amortization (“EBITDA”), further adjusted to exclude unusual items and other adjustments permitted in calculating covenant compliance under the amended senior secured credit facility. We believe that the inclusion of supplementary adjustments to EBITDA applied in presenting Consolidated EBITDA is appropriate to provide additional information to investors to demonstrate compliance with the specified financial ratio and other financial condition tests contained in the amended senior secured credit facility.

Management uses Consolidated EBITDA to gauge the costs of our capital structure on a day-to-day basis when full financial statements are unavailable. Management further believes that providing this information allows our investors greater transparency and a better understanding of our ability to meet our debt service obligations and make capital expenditures.

Consolidated EBITDA does not represent net income or cash flow from operations as those terms are defined by generally accepted accounting principles, or GAAP, and does not necessarily indicate whether cash flows will be sufficient to fund cash needs. Further, the amended senior secured credit facility requires that Consolidated EBITDA be calculated for the most recent four fiscal quarters. As a result, the measure can be disproportionately affected by a particularly strong or weak quarter. Further, it may not be comparable to the measure for any subsequent four-quarter period or any complete fiscal year.

Consolidated EBITDA is not a recognized measurement under GAAP and investors should not consider Consolidated EBITDA as a substitute for measures of our financial performance and liquidity as determined in accordance with GAAP, such as net income, operating income or net cash provided by operating activities. Because other companies may calculate Consolidated EBITDA differently than we do, Consolidated EBITDA may not be comparable to similarly titled measures reported by other companies. Consolidated EBITDA has other limitations as an analytical tool, when compared to the use of net income, which is the most directly comparable GAAP financial measure, including:

•

Consolidated EBITDA does not reflect the significant interest expense we incur as a result of our debt leverage;

•

Consolidated EBITDA does not reflect the provision of income tax expense in our various jurisdictions;

•

Consolidated EBITDA does not reflect any attribution of costs to our operations related to our investments and capital expenditures through depreciation and amortization charges;

•

Consolidated EBITDA does not reflect the cost of compensation we provide to our employees in the form of stock-based awards;

•

Consolidated EBITDA does not reflect the equity in earnings of unconsolidated affiliates; and

•

Consolidated EBITDA excludes expenses and income that are permitted to be excluded per the terms of our amended senior secured credit facility, but which others may believe are normal expenses for the operation of a business.

The following is a reconciliation of net income to Consolidated EBITDA attributable to SS&C common stockholders as defined in our amended senior secured credit facility.


	Three Months Ended March 31,						Twelve Months Ended March 31,
(in millions)	2024			2023			2024
Net income	$	158.0		$	126.2		$	640.4
Interest expense, net		116.0			111.9			473.9
Provision for income taxes		66.7			52.5			263.3
Depreciation and amortization		165.5			165.9			670.1
EBITDA		506.2			456.5			2,047.7
Stock-based compensation		45.1			41.9			162.6
Acquired EBITDA and cost savings (1)		—			—			—
Loss on extinguishment of debt		1.1			0.6			2.7
Equity in earnings of unconsolidated affiliates, net		(2.3	)		(5.7	)		(96.6	)
Purchase accounting adjustments (2)		1.9			2.0			9.1
ASC 606 adoption impact		(0.7	)		(0.7	)		(3.0	)
Foreign currency translation losses (gains)		4.7			(0.5	)		4.9
Investment gains (3)		(10.6	)		(11.2	)		(18.4	)
Facilities and workforce restructuring		12.2			17.8			51.2
Acquisition related (4)		0.8			2.3			(1.6	)
Other (5)		(0.5	)		6.6			0.3
Consolidated EBITDA	$	557.9		$	509.6		$	2,158.9
Consolidated EBITDA attributable to noncontrolling interest (6)		(1.1	)		(0.6	)		(3.4	)
Consolidated EBITDA attributable to SS&C common stockholders	$	556.8		$	509.0		$	2,155.5

________________________

(1)

Acquired EBITDA reflects the EBITDA impact of significant businesses that were acquired during the period as if the acquisition occurred at the beginning of the period, as well as cost savings enacted in connection with acquisitions.

(2)

Purchase accounting adjustments include (a) an adjustment to increase revenues by the amount that would have been recognized if deferred revenue were not adjusted to fair value at the date of acquisitions, (b) an adjustment to increase personnel and commissions expense by the amount that would have been recognized if prepaid commissions and deferred personnel costs were not adjusted to fair value at the date of the acquisitions and (c) an adjustment to increase or decrease rent expense by the amount that would have been recognized if lease obligations were not adjusted to fair value at the date of acquisitions.

(3)

Investment gains includes unrealized fair value adjustments of investments and dividend income received on investments.

(4)

Acquisition related includes costs related to both current acquisitions and the resolution of pre-acquisition matters.

(5)

Other includes additional expenses and income that are permitted to be excluded per the terms of our amended senior secured credit facility from Consolidated EBITDA, a financial measure used in calculating our covenant compliance.

(6)

Consolidated EBITDA attributable to noncontrolling interest represents Consolidated EBITDA based on the ownership interest retained by the noncontrolling parties of DomaniRx, our consolidated variable interest entity.

Our covenant requirement for consolidated net secured leverage ratio and the actual ratio as of March 31, 2024 are as follows:


	Covenant Requirement	Actual Ratio
Maximum consolidated net secured leverage to Consolidated EBITDA ratio(1)	6.25x	2.02x

_____________________________________________________

(1)

Calculated as the ratio of consolidated net secured funded indebtedness, net of cash and cash equivalents, excluding $95.1 million of cash and cash equivalents held at DomaniRx, to Consolidated EBITDA, as defined by the amended senior secured credit facility, for the period of four consecutive fiscal quarters ended on the measurement date. Consolidated net secured funded indebtedness is comprised of indebtedness for borrowed money, letters of credit, deferred purchase price obligations and capital lease obligations, all of which is secured by liens on our property.

Recent Accounting Pronouncements Not Yet Effective

Item 3. Quantitative and Qualitative Disclosures About Market Risk

We do not use derivative financial instruments for trading or speculative purposes. We have generally invested our available cash in short-term, highly liquid financial instruments, having initial maturities of three months or less. When necessary, we have borrowed to fund acquisitions.

Interest Rate Risk

We derive service revenues from investment earnings related to cash balances maintained in bank accounts on which we are the agent for clients. The balances maintained in the bank accounts will fluctuate. For the three months ended March 31, 2024, our average daily cash balances of approximately $1,821.3 million were maintained in such accounts. We estimate that a 100 basis point change in the interest earnings rate would equal approximately $9.7 million of net income, net of income taxes, on an annual basis. The effect of changes in interest rates attributable to earnings derived from cash balances we hold for clients is offset by changes in interest rates on our variable debt.

At March 31, 2024, total variable interest rate debt was approximately $4,675.2 million. As of March 31, 2024, a 100 basis point increase in interest rates would result in an increase in interest expense of approximately $46.8 million per year.

Equity Price Risk

We have exposure to equity price risk as a result of our investments in equity securities. Equity price risk results from changes in the level or volatility of equity prices which affect the value of equity securities or instruments that derive their value from such securities or indexes. The fair value of our investments that are subject to equity price risk as of March 31, 2024 was approximately $49.0 million. The impact of a 10% change in fair value of these investments would have been approximately $3.6 million to net income, net of income taxes. Changes in equity values of our investments could have a material effect on our results of operations and our financial position.

Foreign Currency Exchange Rate Risk

During the three months ended March 31, 2024, approximately 31% of our revenues were from clients located outside the United States. A portion of the revenues from clients located outside the United States is denominated in foreign currencies, the majority being the British pound. While revenues and expenses of our foreign operations are primarily denominated in their respective local currencies, some subsidiaries do enter into certain transactions in currencies that are different from their local currency. These transactions consist primarily of cross-currency intercompany balances and trade receivables and payables. As a result of these transactions, we have exposure to changes in foreign currency exchange rates that result in foreign currency transaction gains and losses, which we report in other income, net. These amounts were not material for the three months ended March 31, 2024. The amount of these balances can fluctuate in the future as we bill customers and buy products or services in currencies other than our functional currency, which could increase our exposure to foreign currency exchange rates. We continue to monitor our exposure to

foreign exchange rates because of our acquisitions and changes in our operations. We do not enter into any market risk sensitive instruments for trading purposes.

The foregoing risk management discussion and the effect thereof are forward-looking statements. Actual results in the future may differ materially from these projected results due to actual developments in global financial markets. The analytical methods used by us to assess and minimize risk discussed above should not be considered projections of future events or losses.

Item 4. Controls and Procedures

Evaluation of Disclosure Controls and Procedures

Our management, with the participation of our chief executive officer and chief financial officer (our principal executive officer and principal financial officer, respectively), evaluated the effectiveness of our disclosure controls and procedures as of March 31, 2024. The term “disclosure controls and procedures,” as defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934, as amended, or Exchange Act, means controls and other procedures of a company that are designed to ensure that information required to be disclosed by a company in the reports that it files or submits under the Exchange Act is recorded, processed, summarized and reported, within the time periods specified in the rules and forms of the Securities and Exchange Commission. Disclosure controls and procedures include, without limitation, controls and procedures designed to ensure that information required to be disclosed by a company in the reports that it files or submits under the Exchange Act is accumulated and communicated to the company’s management, including its principal executive and principal financial officers, as appropriate to allow timely decisions regarding required disclosure. Management recognizes that any controls and procedures, no matter how well designed and operated, can provide only reasonable assurance of achieving their objectives, and management necessarily applies its judgment in evaluating the cost-benefit relationship of possible controls and procedures. Based on the evaluation of our disclosure controls and procedures as of March 31, 2024, our chief executive officer and chief financial officer concluded that, as of such date, our disclosure controls and procedures were effective at the reasonable assurance level.

Changes in Internal Control Over Financial Reporting

There have not been any changes in our internal control over financial reporting (as defined in Rules 13a-15(f) and 15d-15(f) under the Exchange Act) that occurred during the fiscal quarter ended March 31, 2024 that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

PART II – OTHER INFORMATION

Item 1. Legal Proceedings

The information regarding certain legal proceedings in which we are involved as set forth in Note 13 – Commitments and Contingencies of the Notes to the Condensed Consolidated Financial Statements (Part I, Item 1 of this Quarterly Report on Form 10-Q) is incorporated by reference into this Item 1.

In addition, we are involved in various other legal proceedings arising in the normal course of our businesses. At this time, we do not believe any material losses under these claims to be probable. While the ultimate outcome of such legal proceedings cannot be predicted with certainty, it is in the opinion of management, after consultation with legal counsel, that the final outcome in such proceedings, in the aggregate, would not have a material adverse effect on our consolidated financial condition, results of operations or cash flows.

Item 1A. Risk Factors

As of the date of this report, there have been no material changes to the risk factors we previously disclosed in our Annual Report on Form 10-K for the year ended December 31, 2023.

Item 2. Unregistered Sales of Equity Securities, Use of Proceeds, and Issuer Purchases of Equity Securities

The following is a summary of the repurchases of our common stock in the first quarter of 2024 (in millions, except average price per share):


Period (1)	(a) Total Number of Shares Purchased (2)		(b) Average Price Paid per Share		(c) Total Number of Shares Purchased as Part of Publicly Announced Plans or Programs (3)		(d) Maximum Number (or Approximate Dollar Value) of Shares that May Yet be Purchased Under Plans or Programs (3)
January 1, 2024 – January 31, 2024		—	$	—		—	$	772.5
February 1, 2024 – February 29, 2024		—	$	63.81		—	$	769.5
March 1, 2024 – March 31, 2024		0.8	$	63.21		0.8	$	719.6
Total		0.8				0.8

(1) Information is based on trade dates of repurchase transactions.

(2) Represents shares repurchased in open market transactions pursuant to the Common Stock Repurchase Program.

(3) Share repurchases were made pursuant to our Common Stock Repurchase Program, most recently authorized by our Board of Directors in July 2023. The program allows for the purchase of up to $1 billion of outstanding common stock in one or more transactions on the open market or in privately negotiated purchases.

Item 6. Exhibits

The exhibits listed in the Exhibit Index immediately preceding such exhibits are filed as part of this Report.

EXHIBIT INDEX


Exhibit Number		Description of Exhibit

10.1		First Supplemental Indenture, dated as of April 26, 2024, by and among SS&C Technologies, Inc., certain of SS&C Technologies Holdings, Inc.’s subsidiaries, as guarantors, and Wilmington Trust, National Association, as trustee*

31.1		Certification of the Registrant’s Chief Executive Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002*

31.2		Certification of the Registrant’s Chief Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002*

32		Certification of the Registrant’s Chief Executive Officer and Chief Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 (furnished and not filed for purposes of sections 11 or 12 of the Securities Act and section 18 of the Exchange Act)*

101.INS		Inline XBRL Instance Document - the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document.

101.SCH		Inline XBRL Taxonomy Extension Schema Document.*

101.CAL		Inline XBRL Taxonomy Calculation Linkbase Document.*

101.LAB		Inline XBRL Taxonomy Label Linkbase Document.*

101.PRE		Inline XBRL Taxonomy Presentation Linkbase Document.*

101.DEF		Inline XBRL Taxonomy Extension Definition Linkbase Document.*

104		Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101).

* Filed herewith

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.


SS&C TECHNOLOGIES HOLDINGS, INC.

By:		/s/ Brian N. Schell
		Brian N. Schell Executive Vice President and Chief Financial Officer (Duly Authorized Officer, Principal Financial and Accounting Officer)

Date: May 1, 2024